An intervention providing information about inflammatory bowel disease (IBD) can significantly decrease short-term quality of life (QOL)

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 380, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The use of complementary and alternative medicine (CAM) is "highly prevalent" among patients with inflammatory bowel disease (IBD) in Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 429, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Anti Tumor Necrosis Factor-a Monoclonal Antibody (Infliximab) Therapy in Patients with Inflammatory Bowel Disease (IBD): Applications and Side Effects

By  

Drug Design Reviews - Online, Vol. 1, Iss. 2, 2004-01 ,pp. : 111-117

Bentham Science Publishers

Access to resources Recommend Favorite

The Restless Legs Syndrome Quality of Life Instrument (RLS-QLI) is a "reliable and valid" tool for assessing the impact of RLS on patients' lives

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite